{"title":"Activity of XL184 (Cabozantinib), an Oral Tyrosine Kinase Inhibitor, in Patients With Medullary Thyroid Cancer","authors":"M. Schott","doi":"10.1016/J.YEND.2012.03.003","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":23892,"journal":{"name":"Yearbook of Endocrinology","volume":"58 1","pages":"169-171"},"PeriodicalIF":0.0000,"publicationDate":"2012-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"26","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Yearbook of Endocrinology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1016/J.YEND.2012.03.003","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
